Search Results 471-480 of 18075 for insulin response

1. Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Subjects with known diabetes and those taking metformin, sulfonylureas, thiazolidinediones or insulin for any reason ... response to therapy) is not planned ...

2. Urofollitropin (intramuscular route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   FSH is produced in the body by the pituitary gland. FSH helps to develop eggs in the ovaries of women. Urofollitropin will help develop and release eggs in ...

3. Publications - Fernando F. Elli, M.D. - Mayo Clinic

   ... release for median arcuate ligament syndrome: A retrospective study. ... Vitamin D, inflammation, and relations to insulin resistance in premenopausal women with ...

4. Coronary artery disease - Symptoms and causes - Mayo Clinic

   Diabetes or insulin resistance. High blood pressure. Lack of exercise ... Increased high-sensitivity C-reactive protein (hs-CRP). This protein appears ...

5. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

   Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible;; Patients with eczema, psoriasis, lichen simplex chronicus of ...

6. A Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas - Mayo Clinic

   The objective response to binimetinib is defined ... Neurofibroma-associated macrophages play roles in tumor growth and response ... insulin-induced endogenous Ras- ...

7. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

   Negative serum pregnancy test (minimum sensitivity ... Note: Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for ...

8. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

   ... response lasting at least 6 months to first-line platinum-based therapy but ... Replacement therapy (eg, thyroxine, insulin, or physiologic corticosteroid ...

9. Publications - Ekta Kapoor, M.B.B.S. - Mayo Clinic

   Menopause symptoms and the cortisol response. Menopause 2021 Nov 29; 29 ... Effect of insulin infusion on spillover of meal-derived fatty acids. J Clin ...

10. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

    "Refractory" disease: No response to therapy or relapse occurred ≤ 90 days after completion of prior therapy. ... Stable diabetes mellitus on non-insulin therapy ...